Gilead Tshuag nqi 'tsis yog' cuam tshuam nws txoj kev lag luam oncology: Tus kws tshuaj ntsuam

Gilead Sciences Inc.NASDAQ: YOG) tau xaus rau hauv ntsuab rau hnub Tuesday tom qab tus kws tshuaj ntsuam xyuas JPMorgan tig bullish rau lub tuam txhab biopharmaceutical.

Gilead Tshuag yuav tsum muaj nqis txog $80 ib feem

Chriss Schott tam sim no ntsuas lub npe kev noj qab haus huv ntawm "hnyav" thiab pom upside txog $ 80 ib feem - txog 25% nce ntawm no.

Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam? Sau npe rau Invezz cov ntawv xov xwm, hnub no.

Ib qho ntawm cov laj thawj pom tseeb yog vim li cas nws nyiam Gilead Sciences yog nws tus kab mob HIV. Tus kws tshuaj ntsuam sau tias:

Peb muaj nws txoj kev lag luam HIV loj hlob ib tus lej qis CAGR txawm tias thaum ntxov 2030s. Lub sijhawm no, peb pom Biktarvy tseem tshuav cov khoom lag luam tseem ceeb nrog cov nyiaj tau los ntawm $ 10.2 nphom hauv 2022 txog $ 12.5 nphom hauv 2025.

Schott pom lub neej yav tom ntej loj rau Descovy ib yam nkaus.

Lub yim hli ntuj, lub tuam txhab biotech qhia kev lag luam-beating tshwm sim rau nws cov nyiaj txiag lub quarter thib ob. Gilead Tshuag poob qis li ntawm 10% rau lub xyoo.

Gilead Sciences muaj cov nyiaj tau los txaus siab

Lub tuam txhab Nasdaq tseem muaj kev lag luam "oncology", uas, raws li tus kws tshuaj ntsuam xyuas JPMorgan, tsis muaj kev cuam tshuam tag nrho hauv cov nqi tam sim no.

Gilead's HIV kev lag luam ib leeg txhawb nqa tag nrho nws lub khw muag khoom. Nrog rau oncology franchise peb kwv yees mus txog ~ $ 5.0 nphom hauv kev muag khoom los ntawm 2030 nrog rau qhov muaj peev xwm upside rau lenacapravir kwv yees, peb pom cov shares kom meej meej undervalued.

Cov khoom lag luam kho mob tau paub tias ua tau zoo hauv kev lag luam kev lag luam uas yuav los. "Qhov ntawd" nrog cov txiaj ntsig zoo tshaj 4.47% cov nyiaj tau los ua rau nws zoo nkauj dua rau yuav Gilead Tshuag ntawm no.

Cov shares tam sim no ua lag luam zoo hauv qab qhov nruab nrab ntawm lawv cov nqi-rau-nyiaj tau ntau dua tsib xyoos dhau los.  

Luam cov kws ua lag luam yooj yim nrog eToro. Ua lag luam hauv Tshuag xws li Tesla & Apple. Instantly pauv ETFs zoo li FTSE 100 & S&P 500. Sau npe hauv feeb.

10/10

68% ntawm cov khw muag khoom CFD tso nyiaj poob

Tau qhov twg los: https://invezz.com/news/2022/10/05/gilead-stock-doesnt-reflect-oncology-business/